Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-17-000720

Options or other derivatives

  • President and CEO acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Enright William President and CEO 2017-09-22 Grant or award · Stock Options (option to buy) +125,000 125,000 D: show line 1 in the form
Loading xslF345X03/edgar.xml…